02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HEPATOLOGY, VOLUME 62, NUMBER 1 (SUPPL) AASLD ABSTRACTS 481A<br />

both tests, the correct answer was chosen 79% of the time after<br />

the rotation. Conclusion: Our novel curriculum for a non-elective<br />

consult rotation has effectively demonstrated improvement in IM<br />

residents’ comfort with and knowledge of CLD. A trend towards<br />

increased career interest in hepatology was also observed,<br />

which suggests more exposure to CLD could positively impact<br />

recruitment to the workforce.<br />

Disclosures:<br />

Donald M. Jensen - Advisory Committees or Review Panels: Merck, Onom Foundation;<br />

Speaking and Teaching: Gilead<br />

K. Gautham Reddy - Advisory Committees or Review Panels: AASLD Transplant<br />

Hepatology Pilot Steering Committee, ACG Training Committee, Program Director’s<br />

Caucus Steering Committee, Gilead, Inercept, Bristol-Myers Squibb; Grant/<br />

Research Support: Intercept, Ocera, Merck, Lumena<br />

Nancy Reau - Advisory Committees or Review Panels: Jannsen, Merck, AbbVie,<br />

Intercept, Salix, BMS, Jannsen; Grant/Research Support: Merck, Gilead, BMS,<br />

AbbVie, Jannsen, BI<br />

Helen S. Te - Advisory Committees or Review Panels: BMS; Grant/Research<br />

Support: Abbvie, Conatus, BMS<br />

The following authors have nothing to disclose: Adam E. Mikolajczyk, Jeanne M.<br />

Farnan, John F. McConville, Andrew I. Aronsohn<br />

545<br />

High Rates of Hepatitis C Virus Infection Among Inpatient<br />

Baby Boomers in an Urban Hospital: a model to<br />

improve linkage to care<br />

Aparna Goel 1 , Lismeiry Paulino 2 , Douglas Dieterich 2 , Ponni V.<br />

Perumalswami 2 ; 1 Gastroenterology, Icahn School of Medicine<br />

Mount Sinai, New York, NY; 2 Liver Diseases, Icahn School of<br />

Medicine Mount Sinai, New York, NY<br />

Background: New York State passed legislation that took effect<br />

in January 2014 requiring healthcare providers to offer Hepatitis<br />

C Virus (HCV) screening to all inpatient baby boomers<br />

and link infected persons to care. Our aims are to determine<br />

the prevalence of HCV-positive baby boomers admitted to an<br />

urban, tertiary care hospital and evaluate the sequential impact<br />

of an electronic medical record (EMR) prompt, provider education,<br />

and data feedback to providers on HCV screening<br />

and linkage to care rates. Methods: The results of HCV antibody<br />

(Ab) tests for individuals born 1945-1965 with inpatient<br />

encounters at Mount Sinai were obtained from November<br />

2013 through April 2015. The type of medical service, level<br />

of provider and patient demographics were collected. HCV<br />

screening and linkage to care rates before and after a series<br />

of interventions were compared: a birth cohort-selective EMR<br />

prompt was implemented in January 2014, comprehensive<br />

education for housestaff and nurses occurred from July-September<br />

2014, monthly data feedback to nurses with screening<br />

rates began in October 2014 and finally patient navigation<br />

was implemented in May 2015. Results: There were 23,835<br />

inpatient baby boomer encounters during the study period.<br />

The median age was 60 years with 56% male and 33% Hispanic.<br />

Overall, 34% had a documented HCV Ab test and<br />

13% (n=1,036) were positive. Screening rates did not significantly<br />

rise following an EMR prompt (p=0.92), education<br />

(p=0.86) or with data feedback to nursing managers (p=0.42).<br />

Provider education and data feedback interventions led to a<br />

rise in newly diagnosed HCV-positive rates from 6% to 15%<br />

(p576,000<br />

patients receiving AMA testing between January 2010 and<br />

December 2013 in a large US commercial laboratory database.<br />

Patients were considered AMA positive if the antibody<br />

titer was > 1:20 or M2 antibody was > 25.0 U. We examined<br />

geographic distribution at a 3-zip code level. Results: 16,492<br />

patients tested AMA positive and had at least 1 ALP measure<br />

over the 4 year period. 5,380 had an ALP >120 U/l before or<br />

within 30 days of their first AMA+ test and were classified as<br />

having probable PBC. There were clear patterns of increased<br />

concentration of incident PBC patients (from west to east):<br />

Southeastern tip of the Alaskan spur; Santa Barbara/Ventura<br />

and inland central California; western Dakotas’ border; central<br />

Oklahoma including Oklahoma City; western Texas and Houston;<br />

Indiana just north of Louisville, Kentucky; an area of the<br />

Appalachians spanning southeastern New York, southern Pennsylvania,<br />

and the northern West Virginia border; and Florida<br />

(excluding the Pan Handle). These areas were not associated<br />

with age, race/ethnicity, urban concentration, or elevation.<br />

Conclusion: These analyses indicate that there are clusters of<br />

incident patients in geographically diverse areas in the United<br />

States. Additional analyses are required to determine if there<br />

may be geographic or demographic factors underlying these<br />

variations.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!